APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rabies Immune Globulin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rabies Immune Globulin Market Outlook and Growth Opportunities 2026

2 January 2026194 pages

Choose your research edition.

Industry ResearchRabies Immune Globulin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Immune Globulin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Rabies Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Immune Globulin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Immune Globulin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rabies Immune Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rabies Immune Globulin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rabies Immune Globulin market include Sichuan Yuanda Shuyang, Weiguang Bio, Shanghai RAAS, Sanofi, Shuanglin Bio, VINS, Kamada, Grifols and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rabies Immune Globulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Immune Globulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Immune Globulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rabies Immune Globulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Rabies Immune Globulin Segment by Company

Sichuan Yuanda Shuyang

Weiguang Bio

Shanghai RAAS

Sanofi

Shuanglin Bio

VINS

Kamada

Grifols

CSL Behring

CNBG

CBPO

Bharat Serum

Rabies Immune Globulin Segment by Type

ERIG

HRIG

Rabies Immune Globulin Segment by Application

Category II Exposure

Category III Exposure

Rabies Immune Globulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Rabies Immune Globulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rabies Immune Globulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rabies Immune Globulin significant trends, drivers, influence factors in global and regions.

6. To analyze Rabies Immune Globulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Immune Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rabies Immune Globulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Immune Globulin industry.

Chapter 3: Detailed analysis of Rabies Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rabies Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rabies Immune Globulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rabies Immune Globulin Industry Trends Table 2. Rabies Immune Globulin Industry Drivers Table 3. Rabies Immune Globulin Industry Opportunities and Challenges Table 4. Rabies Immune Globulin Industry Restraints Table 5. Global Rabies Immune Globulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rabies Immune Globulin Revenue Share by Company (2021-2026) Table 7. Global Rabies Immune Globulin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Rabies Immune Globulin Sales Volume Share by Company (2021-2026) Table 9. Global Rabies Immune Globulin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Rabies Immune Globulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rabies Immune Globulin Key Company Manufacturing Base & Headquarters Table 12. Global Rabies Immune Globulin Company, Product Type & Application Table 13. Global Rabies Immune Globulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rabies Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ERIG Table 18. Significant Companies of HRIG Table 19. Global Rabies Immune Globulin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Rabies Immune Globulin Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Rabies Immune Globulin Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Rabies Immune Globulin Sales Volume Share by Type (2021-2026) Table 23. Global Rabies Immune Globulin Sales Volume Share by Type (2027-2032) Table 24. Global Rabies Immune Globulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rabies Immune Globulin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rabies Immune Globulin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rabies Immune Globulin Sales Value Share by Type (2021-2026) Table 28. Global Rabies Immune Globulin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Category II Exposure Table 30. Significant Companies of Category III Exposure Table 31. Global Rabies Immune Globulin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Rabies Immune Globulin Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Rabies Immune Globulin Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Rabies Immune Globulin Sales Volume Share by Application (2021-2026) Table 35. Global Rabies Immune Globulin Sales Volume Share by Application (2027-2032) Table 36. Global Rabies Immune Globulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Rabies Immune Globulin Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Rabies Immune Globulin Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Rabies Immune Globulin Sales Value Share by Application (2021-2026) Table 40. Global Rabies Immune Globulin Sales Value Share by Application (2027-2032) Table 41. Global Rabies Immune Globulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Rabies Immune Globulin Sales by Region (2021-2026) & (K Units) Table 43. Global Rabies Immune Globulin Sales Market Share by Region (2021-2026) Table 44. Global Rabies Immune Globulin Sales by Region (2027-2032) & (K Units) Table 45. Global Rabies Immune Globulin Sales Market Share by Region (2027-2032) Table 46. Global Rabies Immune Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Rabies Immune Globulin Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Rabies Immune Globulin Sales Value Share by Region (2021-2026) Table 49. Global Rabies Immune Globulin Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Rabies Immune Globulin Sales Value Share by Region (2027-2032) Table 51. Global Rabies Immune Globulin Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Rabies Immune Globulin Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Rabies Immune Globulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 56. Global Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 57. Global Rabies Immune Globulin Sales by Country (2027-2032) & (K Units) Table 58. Global Rabies Immune Globulin Sales Market Share by Country (2027-2032) Table 59. Global Rabies Immune Globulin Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Rabies Immune Globulin Sales Value Market Share by Country (2021-2026) Table 61. Global Rabies Immune Globulin Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Rabies Immune Globulin Sales Value Market Share by Country (2027-2032) Table 63. Sichuan Yuanda Shuyang Company Information Table 64. Sichuan Yuanda Shuyang Business Overview Table 65. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio Table 67. Sichuan Yuanda Shuyang Recent Development Table 68. Weiguang Bio Company Information Table 69. Weiguang Bio Business Overview Table 70. Weiguang Bio Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Weiguang Bio Rabies Immune Globulin Product Portfolio Table 72. Weiguang Bio Recent Development Table 73. Shanghai RAAS Company Information Table 74. Shanghai RAAS Business Overview Table 75. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shanghai RAAS Rabies Immune Globulin Product Portfolio Table 77. Shanghai RAAS Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sanofi Rabies Immune Globulin Product Portfolio Table 82. Sanofi Recent Development Table 83. Shuanglin Bio Company Information Table 84. Shuanglin Bio Business Overview Table 85. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Shuanglin Bio Rabies Immune Globulin Product Portfolio Table 87. Shuanglin Bio Recent Development Table 88. VINS Company Information Table 89. VINS Business Overview Table 90. VINS Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. VINS Rabies Immune Globulin Product Portfolio Table 92. VINS Recent Development Table 93. Kamada Company Information Table 94. Kamada Business Overview Table 95. Kamada Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Kamada Rabies Immune Globulin Product Portfolio Table 97. Kamada Recent Development Table 98. Grifols Company Information Table 99. Grifols Business Overview Table 100. Grifols Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Grifols Rabies Immune Globulin Product Portfolio Table 102. Grifols Recent Development Table 103. CSL Behring Company Information Table 104. CSL Behring Business Overview Table 105. CSL Behring Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CSL Behring Rabies Immune Globulin Product Portfolio Table 107. CSL Behring Recent Development Table 108. CNBG Company Information Table 109. CNBG Business Overview Table 110. CNBG Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. CNBG Rabies Immune Globulin Product Portfolio Table 112. CNBG Recent Development Table 113. CBPO Company Information Table 114. CBPO Business Overview Table 115. CBPO Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. CBPO Rabies Immune Globulin Product Portfolio Table 117. CBPO Recent Development Table 118. Bharat Serum Company Information Table 119. Bharat Serum Business Overview Table 120. Bharat Serum Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Bharat Serum Rabies Immune Globulin Product Portfolio Table 122. Bharat Serum Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Rabies Immune Globulin Distributors List Table 126. Rabies Immune Globulin Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Rabies Immune Globulin Product Image Figure 2. Global Rabies Immune Globulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rabies Immune Globulin Sales (2021-2032) & (K Units) Figure 5. Global Rabies Immune Globulin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Rabies Immune Globulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ERIG Image Figure 10. HRIG Image Figure 11. Global Rabies Immune Globulin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Rabies Immune Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rabies Immune Globulin Sales Volume Share by Type (2021-2032) Figure 14. Global Rabies Immune Globulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rabies Immune Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rabies Immune Globulin Sales Value Share by Type (2021-2032) Figure 17. Category II Exposure Image Figure 18. Category III Exposure Image Figure 19. Global Rabies Immune Globulin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Rabies Immune Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Rabies Immune Globulin Sales Volume Share by Application (2021-2032) Figure 22. Global Rabies Immune Globulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Rabies Immune Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Rabies Immune Globulin Sales Value Share by Application (2021-2032) Figure 25. Global Rabies Immune Globulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Rabies Immune Globulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Rabies Immune Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Rabies Immune Globulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 30. North America Rabies Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Rabies Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Rabies Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 36. South America Rabies Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Rabies Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Rabies Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Rabies Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Rabies Immune Globulin Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Rabies Immune Globulin Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • ERIG
  • HRIG
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Sichuan Yuanda Shuyang
  • Weiguang Bio
  • Shanghai RAAS
  • Sanofi
  • Shuanglin Bio
  • VINS
  • Kamada
  • Grifols
  • CSL Behring
  • CNBG
  • CBPO
  • Bharat Serum

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rabies Immune Globulin Sales Value (2021-2032)
  4. 1.2.2 Global Rabies Immune Globulin Sales Volume (2021-2032)
  5. 1.2.3 Global Rabies Immune Globulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rabies Immune Globulin Market Dynamics
  1. 2.1 Rabies Immune Globulin Industry Trends
  2. 2.2 Rabies Immune Globulin Industry Drivers
  3. 2.3 Rabies Immune Globulin Industry Opportunities and Challenges
  4. 2.4 Rabies Immune Globulin Industry Restraints
3 Rabies Immune Globulin Market by Company
  1. 3.1 Global Rabies Immune Globulin Company Revenue Ranking in 2025
  2. 3.2 Global Rabies Immune Globulin Revenue by Company (2021-2026)
  3. 3.3 Global Rabies Immune Globulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Rabies Immune Globulin Average Price by Company (2021-2026)
  5. 3.5 Global Rabies Immune Globulin Company Ranking (2024-2026)
  6. 3.6 Global Rabies Immune Globulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Rabies Immune Globulin Company Product Type and Application
  8. 3.8 Global Rabies Immune Globulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rabies Immune Globulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rabies Immune Globulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rabies Immune Globulin Market by Type
  1. 4.1 Rabies Immune Globulin Type Introduction
  2. 4.1.1 ERIG
  3. 4.1.2 HRIG
  4. 4.2 Global Rabies Immune Globulin Sales Volume by Type
  5. 4.2.1 Global Rabies Immune Globulin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rabies Immune Globulin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rabies Immune Globulin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rabies Immune Globulin Sales Value by Type
  9. 4.3.1 Global Rabies Immune Globulin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rabies Immune Globulin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rabies Immune Globulin Sales Value Share by Type (2021-2032)
5 Rabies Immune Globulin Market by Application
  1. 5.1 Rabies Immune Globulin Application Introduction
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Rabies Immune Globulin Sales Volume by Application
  5. 5.2.1 Global Rabies Immune Globulin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Rabies Immune Globulin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Rabies Immune Globulin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Rabies Immune Globulin Sales Value by Application
  9. 5.3.1 Global Rabies Immune Globulin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Rabies Immune Globulin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Rabies Immune Globulin Sales Value Share by Application (2021-2032)
6 Rabies Immune Globulin Regional Sales and Value Analysis
  1. 6.1 Global Rabies Immune Globulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Immune Globulin Sales by Region (2021-2032)
  3. 6.2.1 Global Rabies Immune Globulin Sales by Region: 2021-2026
  4. 6.2.2 Global Rabies Immune Globulin Sales by Region (2027-2032)
  5. 6.3 Global Rabies Immune Globulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rabies Immune Globulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rabies Immune Globulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rabies Immune Globulin Sales Value by Region (2027-2032)
  9. 6.5 Global Rabies Immune Globulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rabies Immune Globulin Sales Value (2021-2032)
  12. 6.6.2 North America Rabies Immune Globulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rabies Immune Globulin Sales Value (2021-2032)
  15. 6.7.2 Europe Rabies Immune Globulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rabies Immune Globulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rabies Immune Globulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rabies Immune Globulin Sales Value (2021-2032)
  21. 6.9.2 South America Rabies Immune Globulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rabies Immune Globulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rabies Immune Globulin Sales Value Share by Country, 2025 VS 2032
7 Rabies Immune Globulin Country-level Sales and Value Analysis
  1. 7.1 Global Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rabies Immune Globulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rabies Immune Globulin Sales by Country (2021-2032)
  4. 7.3.1 Global Rabies Immune Globulin Sales by Country (2021-2026)
  5. 7.3.2 Global Rabies Immune Globulin Sales by Country (2027-2032)
  6. 7.4 Global Rabies Immune Globulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rabies Immune Globulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rabies Immune Globulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rabies Immune Globulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rabies Immune Globulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rabies Immune Globulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Yuanda Shuyang
  2. 8.1.1 Sichuan Yuanda Shuyang Company Information
  3. 8.1.2 Sichuan Yuanda Shuyang Business Overview
  4. 8.1.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio
  6. 8.1.5 Sichuan Yuanda Shuyang Recent Developments
  7. 8.2 Weiguang Bio
  8. 8.2.1 Weiguang Bio Company Information
  9. 8.2.2 Weiguang Bio Business Overview
  10. 8.2.3 Weiguang Bio Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Bio Rabies Immune Globulin Product Portfolio
  12. 8.2.5 Weiguang Bio Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS Rabies Immune Globulin Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Rabies Immune Globulin Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Shuanglin Bio
  26. 8.5.1 Shuanglin Bio Company Information
  27. 8.5.2 Shuanglin Bio Business Overview
  28. 8.5.3 Shuanglin Bio Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shuanglin Bio Rabies Immune Globulin Product Portfolio
  30. 8.5.5 Shuanglin Bio Recent Developments
  31. 8.6 VINS
  32. 8.6.1 VINS Company Information
  33. 8.6.2 VINS Business Overview
  34. 8.6.3 VINS Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 VINS Rabies Immune Globulin Product Portfolio
  36. 8.6.5 VINS Recent Developments
  37. 8.7 Kamada
  38. 8.7.1 Kamada Company Information
  39. 8.7.2 Kamada Business Overview
  40. 8.7.3 Kamada Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kamada Rabies Immune Globulin Product Portfolio
  42. 8.7.5 Kamada Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Grifols Rabies Immune Globulin Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 CSL Behring
  50. 8.9.1 CSL Behring Company Information
  51. 8.9.2 CSL Behring Business Overview
  52. 8.9.3 CSL Behring Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CSL Behring Rabies Immune Globulin Product Portfolio
  54. 8.9.5 CSL Behring Recent Developments
  55. 8.10 CNBG
  56. 8.10.1 CNBG Company Information
  57. 8.10.2 CNBG Business Overview
  58. 8.10.3 CNBG Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CNBG Rabies Immune Globulin Product Portfolio
  60. 8.10.5 CNBG Recent Developments
  61. 8.11 CBPO
  62. 8.11.1 CBPO Company Information
  63. 8.11.2 CBPO Business Overview
  64. 8.11.3 CBPO Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CBPO Rabies Immune Globulin Product Portfolio
  66. 8.11.5 CBPO Recent Developments
  67. 8.12 Bharat Serum
  68. 8.12.1 Bharat Serum Company Information
  69. 8.12.2 Bharat Serum Business Overview
  70. 8.12.3 Bharat Serum Rabies Immune Globulin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bharat Serum Rabies Immune Globulin Product Portfolio
  72. 8.12.5 Bharat Serum Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rabies Immune Globulin Value Chain Analysis
  2. 9.1.1 Rabies Immune Globulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rabies Immune Globulin Sales Mode & Process
  6. 9.2 Rabies Immune Globulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rabies Immune Globulin Distributors
  9. 9.2.3 Rabies Immune Globulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst